Syngene International Ltd.
Snapshot View

602.60 -6.15 ▼-1.0%

28 November 2022, 04:09:18 PM
Volume: 276,562

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syngeneintl.com
Market Cap 24,200.48 Cr.
Enterprise Value(EV) 24,685.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.65 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 56.42 Trailing Twelve Months Ending 2022-09
Industry PE 35.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 81.56 Trailing Twelve Months Ending 2022-09
Price to Book Value 7.37 Calculated using Price: 601.10
Dividend Yield 0.17 Period Ending 2022-03
No. of Shares Subscribed 40.14 Cr. 401,434,500 Shares
FaceValue 10
Company Profile
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Services offered by the company are Discovery Chemistry, Discovery Biology, Safety Assessment, Large Molecule Development, Chemical Development, Formulation Development, Stability Studies, Polymer Research, Integrated Discovery & Development, Clinical Development Services, Bioinformatics, Antibody Drug Conjugates, Oligonucleotide Synthesis.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.01%
1 Week
+0.40%
1 Month
-1.73%
3 Month
+0.42%
6 Month
+13.28%
1 Year
+2.18%
2 Year
+4.27%
5 Year
+124.22%
10 Year
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.05 18.26 20.21 16.59 13.29
Return on Capital Employed (%) 15.76 16.98 19.60 15.40 13.24
Return on Assets (%) 9.80 9.86 10.77 9.17 7.69

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,720 1,968 2,176 2,821 3,298 3,274
Non Curr. Liab. 613 515 325 840 972 968
Curr. Liab. 784 1,129 1,539 1,133 1,229 1,035
Minority Int.
Equity & Liab. 3,117 3,612 4,040 4,794 5,498 5,277
Non Curr. Assets 1,396 1,848 2,428 2,987 3,292 3,275
Curr. Assets 1,720 1,764 1,613 1,807 2,206 2,002
Misc. Exp. not W/O
Total Assets 3,117 3,612 4,040 4,794 5,498 5,277

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,423 1,826 2,012 2,184 2,604 2,812
Other Income 136 76 96 83 108 88
Total Income 1,559 1,902 2,108 2,268 2,713 2,900
Total Expenditure -1,033 -1,290 -1,409 -1,531 -1,864 -1,998
PBIDT 527 612 700 736 849 902
Interest -23 -32 -35 -28 -24 -36
Depreciation -131 -164 -219 -275 -310 -335
Taxation -67 -84 -105 -64 -89 -103
Exceptional Items 71 35 -31
PAT 305 332 412 405 396 428
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 305 332 412 405 396 428
Adjusted EPS 8 8 10 10 10 11

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 446 630 677 701 581
Cash Fr. Inv. -349 -647 -428 -628 -612
Cash Fr. Finan. -79 -72 -226 58 -31
Net Change 18 -89 23 131 -62
Cash & Cash Eqvt 253 165 193 323 262

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 70.61 70.59 70.58 70.43 70.42 70.41 70.41 70.29 64.86
Public 29.39 29.41 29.42 29.57 29.58 29.59 29.59 29.71 35.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Syngene International Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call
Tue, 22 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Syngene International Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call
Mon, 21 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Syngene International Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Mon, 28 Nov 2022
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 5 Years High Increase 5 Years
Close Crossing 20 EMA From Above Close Crossing 20 EMA From Above
RSI Trending Down RSI Trending Down

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Syngene International Ltd.

What is Syngene Internation. share price?

Can I buy Syngene Internation. shares now?

What is the Dividend Yield of Syngene Internation.?

What is the Market Cap of Syngene Internation.?

What are the key metrics to analyse Syngene Internation.?

What is the 52 Week High and Low of Syngene Internation.?

What is the trend of Syngene Internation. share price?